For a Harvard-experienced health practitioner with more than thirty several years in medication—including decades treating cancer patients ahead of transitioning to integrative medicine—I come across myself in a novel placement. I fully grasp the biohacking enthusiasm, but I also respect the rigorous skepticism of oncology.Be part of Waitlist W